FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167715051> ?p ?o ?g. }

• W2167715051 endingPage "457" @default.
• W2167715051 startingPage "450" @default.
• W2167715051 abstract "Cariprazine is an orally active and potent D3 and D2 partial agonist with preferential binding to D3 receptors in development for the treatment of schizophrenia and bipolar mania. This study (NCT00694707) evaluated the efficacy and safety of cariprazine in patients with acute exacerbation of schizophrenia. This study was a multinational, double-blind, randomized, placebo- and active-controlled, fixed-dose trial. Patients were randomized to receive placebo, cariprazine 1.5 mg/d, cariprazine 3.0 mg/d, cariprazine 4.5 mg/d, or risperidone 4.0 mg/d (for assay sensitivity) for 6 weeks of double-blind treatment and 2 weeks of safety follow-up. Primary and secondary efficacy parameters were change from baseline to Week 6 in Positive and Negative Syndrome Scale (PANSS) total and Global Impressions-Severity of Illness (CGI-S) scores, respectively. Safety parameters included adverse events (AEs), vital signs, laboratory measures, and extrapyramidal symptom (EPS) scales. Of 732 randomized patients, 64% completed the study. PANSS total score improvement at Week 6 was statistically significant versus placebo for cariprazine 1.5 mg/d, 3.0 mg/d, and 4.5 mg/d (least squares mean difference [LSMD]: − 7.6, − 8.8, − 10.4, respectively; p < 0.001; LOCF) and risperidone (− 15.1, p < 0.001; LOCF); significant improvement on CGI-S was demonstrated for all active treatments (p < 0.05). The most frequent cariprazine AEs (≥ 5% and at least twice the rate of the placebo group) were insomnia, extrapyramidal disorder, akathisia, sedation, nausea, dizziness, and constipation. Mean changes in metabolic parameters were small and similar between groups. The results of this study support the efficacy and safety of cariprazine in patients with acute exacerbation of schizophrenia." @default.
• W2167715051 created "2016-06-24" @default.
• W2167715051 creator A5007300327 @default.
• W2167715051 creator A5013825927 @default.
• W2167715051 creator A5023885494 @default.
• W2167715051 creator A5032720710 @default.
• W2167715051 creator A5033804720 @default.
• W2167715051 creator A5039779042 @default.
• W2167715051 creator A5060763145 @default.
• W2167715051 date "2014-02-01" @default.
• W2167715051 modified "2023-10-17" @default.
• W2167715051 title "An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial" @default.
• W2167715051 cites W1567262959 @default.
• W2167715051 cites W1969447966 @default.
• W2167715051 cites W1973633295 @default.
• W2167715051 cites W1976392791 @default.
• W2167715051 cites W1993329643 @default.
• W2167715051 cites W1999689270 @default.
• W2167715051 cites W2035408447 @default.
• W2167715051 cites W2051869406 @default.
• W2167715051 cites W2072245045 @default.
• W2167715051 cites W2080653012 @default.
• W2167715051 cites W2087350224 @default.
• W2167715051 cites W2096463856 @default.
• W2167715051 cites W2105454368 @default.
• W2167715051 cites W2107325590 @default.
• W2167715051 cites W2121313171 @default.
• W2167715051 cites W2124201657 @default.
• W2167715051 cites W2140606211 @default.
• W2167715051 cites W2145467714 @default.
• W2167715051 cites W2159155203 @default.
• W2167715051 cites W2162105640 @default.
• W2167715051 cites W2165379748 @default.
• W2167715051 cites W2167223183 @default.
• W2167715051 cites W2170792659 @default.
• W2167715051 cites W4229844282 @default.
• W2167715051 cites W4242468065 @default.
• W2167715051 doi "https://doi.org/10.1016/j.schres.2013.11.041" @default.
• W2167715051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24412468" @default.
• W2167715051 hasPublicationYear "2014" @default.
• W2167715051 type Work @default.
• W2167715051 sameAs 2167715051 @default.
• W2167715051 citedByCount "143" @default.
• W2167715051 countsByYear W21677150512014 @default.
• W2167715051 countsByYear W21677150512015 @default.
• W2167715051 countsByYear W21677150512016 @default.
• W2167715051 countsByYear W21677150512017 @default.
• W2167715051 countsByYear W21677150512018 @default.
• W2167715051 countsByYear W21677150512019 @default.
• W2167715051 countsByYear W21677150512020 @default.
• W2167715051 countsByYear W21677150512021 @default.
• W2167715051 countsByYear W21677150512022 @default.
• W2167715051 countsByYear W21677150512023 @default.
• W2167715051 crossrefType "journal-article" @default.
• W2167715051 hasAuthorship W2167715051A5007300327 @default.
• W2167715051 hasAuthorship W2167715051A5013825927 @default.
• W2167715051 hasAuthorship W2167715051A5023885494 @default.
• W2167715051 hasAuthorship W2167715051A5032720710 @default.
• W2167715051 hasAuthorship W2167715051A5033804720 @default.
• W2167715051 hasAuthorship W2167715051A5039779042 @default.
• W2167715051 hasAuthorship W2167715051A5060763145 @default.
• W2167715051 hasBestOaLocation W21677150511 @default.
• W2167715051 hasConcept C118552586 @default.
• W2167715051 hasConcept C126322002 @default.
• W2167715051 hasConcept C142724271 @default.
• W2167715051 hasConcept C15744967 @default.
• W2167715051 hasConcept C168563851 @default.
• W2167715051 hasConcept C170493617 @default.
• W2167715051 hasConcept C197934379 @default.
• W2167715051 hasConcept C204787440 @default.
• W2167715051 hasConcept C27081682 @default.
• W2167715051 hasConcept C2776412080 @default.
• W2167715051 hasConcept C2777014857 @default.
• W2167715051 hasConcept C2777393122 @default.
• W2167715051 hasConcept C2778938600 @default.
• W2167715051 hasConcept C2779727114 @default.
• W2167715051 hasConcept C2780057945 @default.
• W2167715051 hasConcept C2780135775 @default.
• W2167715051 hasConcept C2780494398 @default.
• W2167715051 hasConcept C2780616385 @default.
• W2167715051 hasConcept C2780634440 @default.
• W2167715051 hasConcept C58732023 @default.
• W2167715051 hasConcept C71924100 @default.
• W2167715051 hasConcept C90924648 @default.
• W2167715051 hasConceptScore W2167715051C118552586 @default.
• W2167715051 hasConceptScore W2167715051C126322002 @default.
• W2167715051 hasConceptScore W2167715051C142724271 @default.
• W2167715051 hasConceptScore W2167715051C15744967 @default.
• W2167715051 hasConceptScore W2167715051C168563851 @default.
• W2167715051 hasConceptScore W2167715051C170493617 @default.
• W2167715051 hasConceptScore W2167715051C197934379 @default.
• W2167715051 hasConceptScore W2167715051C204787440 @default.
• W2167715051 hasConceptScore W2167715051C27081682 @default.
• W2167715051 hasConceptScore W2167715051C2776412080 @default.
• W2167715051 hasConceptScore W2167715051C2777014857 @default.
• W2167715051 hasConceptScore W2167715051C2777393122 @default.
• W2167715051 hasConceptScore W2167715051C2778938600 @default.
• W2167715051 hasConceptScore W2167715051C2779727114 @default.

• next